Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with recurrent oral squamous cell carcinoma treated with nivolumab
Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with recurrent oral squamous cell carcinoma treated with nivolumab
复制标题
中性粒细胞与淋巴细胞比率作为接受纳武单抗治疗的复发性口腔鳞状细胞癌患者预后的早期标志物
DOI：
10.1016/j.bjoms.2023.03.012
复制
发表时间：
2023
影响因子：
1.8
通讯作者：
Noguchi Makoto
中科院分区：
文献类型：
--
作者：
Tachinami Hidetake;Tomihara Kei;Yamada Shin-ichi;Ikeda Atsushi;Imaue Shuichi;Noguchi Makoto
